Abstract:A monoselective synthesis of aryl-C-Δ(1,2)-glycosides from 1-iodoglycals via palladium-catalyzed ortho-C-H activation of N-quinolyl benzamides has been developed. An amino acid derivative was used as a crucial ligand to improve the yield and monoselectivity of the coupling reaction. The utility of this protocol was demonstrated by a concise synthesis of key moieties of some natural products.
“…A Pd-based catalytic system was used by Wu and Ye to achieve the functionalisation of arenecarboxamides with 1-iodoglycals. 423 An additional ligand derived from l -proline was required to obtain good to high yields (51–91%) and mono-selectivity ( Scheme 69D ), even if traces of diglycosylated compounds were generally detected. Various substituents on the amide partner were tolerated, such as a bromine atom particularly useful for further post-modifications.…”
“…A Pd-based catalytic system was used by Wu and Ye to achieve the functionalisation of arenecarboxamides with 1-iodoglycals. 423 An additional ligand derived from l -proline was required to obtain good to high yields (51–91%) and mono-selectivity ( Scheme 69D ), even if traces of diglycosylated compounds were generally detected. Various substituents on the amide partner were tolerated, such as a bromine atom particularly useful for further post-modifications.…”
“…However, many existing methods resort to pre-functionalized coupling partners of high reactivity (such as metallated arenes/alkanes for nucleophilic substitution and metal-catalysed cross-coupling), [4] lack general regiochemical control (such as Friedel-Crafts-type glycosylation), [5] and often require a multistep reaction sequence and delicate operating conditions. [6] Recently, several groups have reported elegant methods for the synthesis of C-aryl glycosides via C À H functionalization [6,7] by applying metal-catalyzed activation of aryl C À H bond and avoiding pre-activation of the acceptors in the glycosylation. These methods offer a mild, straightforward, efficient, and general strategy for the synthesis of a series of C-aryl glycosides.…”
We have developed a highly efficient and practical approach for palladium‐catalyzed trifluoroacetate‐promoted N‐quinolylcarboxamide‐directed glycosylation of inert β‐C(sp3)−H bonds of N‐phthaloyl α‐amino acids with glycals under mild conditions. For the first time, C(sp3)−H activation for glycosylation was achieved to build C‐alkyl glycosides. This method facilitates the synthesis of various β‐substituted C‐alkyl glycoamino acids and offers a tool for glycopeptide synthesis.
“…Most recently, Wu, Ye and co‐workers discovered a new approach for the synthesis of diverse C ‐aryl glycals (aryl‐ C ‐Δ 1,2 ‐glycosides, cf. 256 – 263 , Table ) from various 1‐iodoglycals 254 and N ‐quinolyl benzamides 253 via palladium‐catalyzed ortho ‐C–H activation . As shown in Table , various C ‐aryl glycals 256 – 263 were obtained in good to excellent yields under optimal condition {10 mol‐% Pd(OAc) 2 , 30 mol‐% ligand ( 255 ), 2 equiv.…”
Section: Synthesis Of O‐ N‐ C‐ and S‐glycosides By Group 10 Metmentioning
Development of efficient, mild, and easily operable stereoselective glycosylations is of critical importance to access sufficient amounts of pure and structurally well‐defined carbohydrates for studies of their biological functions. Such studies will facilitate our understanding of the role of complex oligosaccharides and glycoconjugates in biological processes as well as the development of carbohydrate‐based effective therapeutic agents. This review highlights recent advances in the transition metal catalyzed stereoselective glycosylations for the synthesis of a variety of structurally complex and biologically significant O‐, N‐, C‐, and S‐glycosides.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.